Mesh Bio, a health deep tech startup, secured investment from East Ventures

Mesh Bio, a Singapore-based health deep tech startup in transforming chronic disease management through predictive analytics, announced that it had raised an undisclosed amount of funding from East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia. The funding will be allocated to further develop the digital twin technologies in chronic disease management and to expand its services across Southeast Asia, mainly Indonesia, Malaysia, and the Philippines.

Singapore-based healthtech startup Smarter Health raises S$ 5.15 million to transform healthcare in the region

Smarter Health, a Singapore-based healthtech startup, announced that it has secured S$ 5.15 million in series A funding led by East Ventures. The funds will be used primarily for product development and market expansion in Southeast Asia.